Fecal and urinary adipokines as disease biomarkers

HC Tews, T Elger, T Grewal, S Weidlich, F Vitali… - Biomedicines, 2023 - mdpi.com
The use of biomarkers is of great clinical value for the diagnosis and prognosis of disease
and the assessment of treatment efficacy. In this context, adipokines secreted from adipose …

[HTML][HTML] Role of the Innate Immune Response in Glomerular Disease Pathogenesis: Focus on Podocytes

W Issa, R Njeim, A Carrazco, GW Burke, A Mitrofanova - Cells, 2024 - mdpi.com
Accumulating evidence indicates that inflammatory and immunologic processes play a
significant role in the development and progression of glomerular diseases. Podocytes, the …

Efficacy of combined rituximab and daratumumab treatment in posttransplant recurrent focal segmental glomerulosclerosis

A Angeletti, S Bin, A Magnasco, M Bruschi… - American Journal of …, 2024 - Elsevier
Focal segmental glomerulosclerosis (FSGS) is one of the leading causes of kidney failure
and it is characterized by a high rate of recurrence after kidney transplant. Moreover, FSGS …

Sparsentan: A First-in-class dual endothelin and angiotensin II receptor antagonist

AW Chiu, N Bredenkamp - Annals of Pharmacotherapy, 2024 - journals.sagepub.com
Objective: To provide an overview of the guidelines on the management of immunoglobulin
A nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS), review the evidence …

[HTML][HTML] Glomerular Diseases Across Lifespan: Key Differences in Diagnostic and Therapeutic Approaches

M Windpessl, B Odler, IM Bajema, D Geetha… - Seminars in …, 2023 - Elsevier
Glomerular diseases are common causes of chronic kidney disease in childhood,
adolescence, and adulthood. The epidemiology of glomerular diseases differs between …

Curcumin ameliorates focal segmental glomerulosclerosis by inhibiting apoptosis and oxidative stress in podocytes

H Zhang, QQ Dong, HP Shu, YC Tu, QQ Liao… - Archives of Biochemistry …, 2023 - Elsevier
Focal segmental glomerulosclerosis (FSGS), a podocyte disease, is the leading cause of
end-stage renal disease (ESRD). Nevertheless, the current effective treatment for FSGS is …

Management of focal segmental glomerulosclerosis in resource-limited regions

S Banerjee, M Bonilla-Felix - Pediatric Nephrology, 2024 - Springer
The management of focal segmental glomerulosclerosis (FSGS) is challenging, and a
definitive long-term cure remains elusive. It is associated with poor outcomes due to …

Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group

S Mirioglu, L Daniel-Fischer, I Berke… - Nephrology Dialysis …, 2024 - academic.oup.com
The histopathological lesions, minimal change disease (MCD) and focal segmental
glomerulosclerosis (FSGS) are entities without immune complex deposits which can cause …

[HTML][HTML] Phellinus igniarius ameliorates renal aging in a rat model of focal and segmental glomerulosclerosis

ZT Wang, YW Tang, F Wan, RC Yang… - Asian Pacific Journal …, 2023 - journals.lww.com
Objective: To comparatively investigate the ameliorative effect of Phellinus igniarius (P.
igniarius) on renal aging in a rat model of focal and segmental glomerulosclerosis (FSGS) …

Pemphigus vulgaris and focal segmental glomerulosclerosis (FSGS): First reported case and a review of the literature

A Sadeghzadeh‐Bazargan, A Amouzegar… - Clinical Case …, 2023 - Wiley Online Library
Key Clinical Message There may be a connection between pemphigus vulgaris and
nephrotic syndrome, as evidenced by the occurrence of focal segmental glomerulosclerosis …